BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34515538)

  • 1. SARS-CoV-2 and the Eye: The Pandora's Box of Ocular Immunology.
    Neri P; Pichi F
    J Ocul Pharmacol Ther; 2021 Nov; 37(9):502-509. PubMed ID: 34515538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 in Immunocompromised Patients: A Systematic Review.
    Stainer A; Amati F; Suigo G; Simonetta E; Gramegna A; Voza A; Aliberti S
    Semin Respir Crit Care Med; 2021 Dec; 42(6):839-858. PubMed ID: 34918325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
    Bilal M; Iqbal HMN
    Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the Complexities of Severe Acute Respiratory Syndrome Coronavirus 2: A Comprehensive Ophthalmic and Systemic Perspective.
    Neri P; Perez Y; Agarwal A; Pichi F
    J Ocul Pharmacol Ther; 2024 Jun; 40(5):253-258. PubMed ID: 38669054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 6. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.
    Bai Z; Cao Y; Liu W; Li J
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment.
    Rezaei Z; Mobasheri L; Sadri F
    DNA Cell Biol; 2021 Jul; 40(7):858-868. PubMed ID: 33989051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Immunopathogenesis of Pregnancy With COVID-19 at the Vaccination Era.
    Lv D; Peng J; Long R; Lin X; Wang R; Wu D; He M; Liao S; Zhao Y; Deng D
    Front Immunol; 2021; 12():683440. PubMed ID: 34305916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 vaccine candidates in rapid development.
    Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H
    Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies.
    Payandeh Z; Mohammadkhani N; Nabi Afjadi M; Khalili S; Rajabibazl M; Houjaghani Z; Dadkhah M
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):899-910. PubMed ID: 33307883
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronaviruses and Endocrine System: A Systematic Review on Evidence and Shadows.
    Parolin M; Parisotto M; Zanchetta F; Sartorato P; De Menis E
    Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1242-1251. PubMed ID: 32888287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2: Unique Challenges of the Virus and Vaccines.
    Mahmoodpoor A; Sanaie S; Samadi P; Yousefi M; Nader ND
    Immunol Invest; 2021 Oct; 50(7):802-809. PubMed ID: 34109900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies.
    Kitazawa K; Deinhardt-Emmer S; Inomata T; Deshpande S; Sotozono C
    Cells; 2021 Apr; 10(4):. PubMed ID: 33918318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology of COVID-19.
    Brüssow H
    Environ Microbiol; 2020 Dec; 22(12):4895-4908. PubMed ID: 33145867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targets and strategies for vaccine development against SARS-CoV-2.
    Malik JA; Mulla AH; Farooqi T; Pottoo FH; Anwar S; Rengasamy KRR
    Biomed Pharmacother; 2021 May; 137():111254. PubMed ID: 33550049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals.
    Seah I; Agrawal R
    Ocul Immunol Inflamm; 2020 Apr; 28(3):391-395. PubMed ID: 32175797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.